Bath Savings Trust Co Buys 10,626 Shares of Colgate-Palmolive Company $CL

Key Points

• Bath Savings Trust Co increased its holdings in Colgate-Palmolive Company by 15.3% in the 2nd quarter, owning a total of 80,294 shares worth approximately $7.3 million.
• Analysts have varied opinions on the stock, with a consensus rating of Moderate Buy and an average price target of $98.00.
• Colgate-Palmolive recently reported an EPS of $0.92, exceeding expectations, with quarterly revenue up 1.0% year-over-year.

Bath Savings Trust Co grew its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 15.3% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 80,294 shares of the company's stock after purchasing an additional 10,626 shares during the quarter. Bath Savings Trust Co's holdings in Colgate-Palmolive were worth $7,299,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $285,000. Vision Capital Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $322,000. Autumn Glory Partners LLC increased its stake in shares of Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after buying an additional 3,586 shares during the period. Financial Gravity Asset Management Inc. acquired a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $2,166,000. Finally, Penserra Capital Management LLC boosted its position in shares of Colgate-Palmolive by 398.6% in the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after purchasing an additional 8,515 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on CL. Morgan Stanley reduced their price target on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. JPMorgan Chase & Co. lowered their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. Citigroup lowered their price target on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. UBS Group decreased their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Finally, Wells Fargo & Company cut their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating for the company in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average target price of $98.00.

Colgate-Palmolive Trading Down 0.4%

Colgate-Palmolive stock traded down $0.30 during mid-day trading on Friday, hitting $81.23. The company's stock had a trading volume of 14,727,470 shares, compared to its average volume of 4,511,123. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market cap of $65.65 billion, a price-to-earnings ratio of 22.82, a price-to-earnings-growth ratio of 4.24 and a beta of 0.35. The business has a 50 day moving average price of $84.97 and a 200-day moving average price of $89.22. Colgate-Palmolive Company has a 12 month low of $81.01 and a 12 month high of $104.49.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analysts' expectations of $5.03 billion. During the same quarter in the previous year, the company earned $0.91 earnings per share. The company's revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive's payout ratio is presently 58.43%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.